About this data
What it is
An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
Who files it
The investor, within days of crossing 5%, and again whenever the stake changes materially.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.

All of this comes from public filings.

Filings per day, last 30 days

0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0
0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0

13D (activist) 13G (passive)

Latest ownership filings

Reset

Showing: ticker NGNE

Latest ownership filings
FiledScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders.CompanyInvestorShares% of sharesFiling
Oct 7, 2026SCHEDULE 13GNGNE
Neurogene Inc.
Prudential Financial Inc2.23M11.2%SCHEDULE 13G ↗
Oct 6, 2026SCHEDULE 13GNGNE
Neurogene Inc.
Jennison Associates LLC2.23M11.1%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Ortav Yehudai714,8854.5%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Trails Edge Biotechnology Master Fund, LP714,8854.5%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Trails Edge Capital Partners, LP714,8854.5%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13GNGNE
Neurogene Inc.
Dmitry Balyasny818,7065.2%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GNGNE
Neurogene Inc.
Dames GP LLC818,7065.2%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GNGNE
Neurogene Inc.
Balyasny Asset Management Holdings LP818,7065.2%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GNGNE
Neurogene Inc.
Bam GP LLC818,7065.2%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GNGNE
Neurogene Inc.
Balyasny Asset Management L.P.818,7065.2%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Redmile Biopharma Investments I, L.P.812,0335.1%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Jeremy C. Green1.57M9.9%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Redmile Group, LLC1.57M9.9%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Redmile Biopharma Investments I, L.P.749,6104.8%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Jeremy C. Green1.56M9.9%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Redmile Group, LLC1.56M9.9%SCHEDULE 13G/A ↗
Dec 15, 2025SCHEDULE 13GNGNE
Neurogene Inc.
Ortav Yehudai785,0005.1%SCHEDULE 13G ↗
Dec 15, 2025SCHEDULE 13GNGNE
Neurogene Inc.
Trails Edge Biotechnology Master Fund, LP785,0005.1%SCHEDULE 13G ↗
Dec 15, 2025SCHEDULE 13GNGNE
Neurogene Inc.
Trails Edge Capital Partners, LP785,0005.1%SCHEDULE 13G ↗
Nov 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
EcoR1 Capital Fund Qualified, L.P.1.25M8.6%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Oleg Nodelman1.44M9.9%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
EcoR1 Capital, LLC1.44M9.9%SCHEDULE 13G/A ↗
Aug 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Commodore Capital Master LP427,8663.0%SCHEDULE 13G/A ↗
Aug 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Commodore Capital LP427,8663.0%SCHEDULE 13G/A ↗
Aug 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Felix J. Baker991,8047.0%SCHEDULE 13G/A ↗
Aug 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Julian C. Baker991,8047.0%SCHEDULE 13G/A ↗
Aug 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Baker Bros. Advisors (GP) LLC991,6917.0%SCHEDULE 13G/A ↗
Aug 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Baker Bros. Advisors LP991,6917.0%SCHEDULE 13G/A ↗
May 15, 2025SCHEDULE 13GNGNE
Neurogene Inc.
Felix J. Baker1.49M10.0%SCHEDULE 13G ↗
May 15, 2025SCHEDULE 13GNGNE
Neurogene Inc.
Julian C. Baker1.49M10.0%SCHEDULE 13G ↗
May 15, 2025SCHEDULE 13GNGNE
Neurogene Inc.
Baker Bros. Advisors (GP) LLC1.49M9.9%SCHEDULE 13G ↗
May 15, 2025SCHEDULE 13GNGNE
Neurogene Inc.
Baker Bros. Advisors LP1.49M9.9%SCHEDULE 13G ↗
May 12, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Abigail P. Johnson462,8793.1%SCHEDULE 13G/A ↗
May 12, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
FMR LLC462,8793.1%SCHEDULE 13G/A ↗
Apr 23, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
BlackRock, Inc.1.01M6.8%SCHEDULE 13G/A ↗
Feb 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Janus Henderson Group PLC00.0%SCHEDULE 13G/A ↗
Feb 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Ms. Lillian Nordahl442,7613.0%SCHEDULE 13G/A ↗
Feb 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Dr. Jeffrey R. Jay, M.D.442,7613.0%SCHEDULE 13G/A ↗
Feb 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Great Point Partners, LLC442,7613.0%SCHEDULE 13G/A ↗
Feb 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Redmile Biopharma Investments I, L.P.812,0335.4%SCHEDULE 13G/A ↗
Feb 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Jeremy C. Green1.48M9.9%SCHEDULE 13G/A ↗
Feb 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Redmile Group, LLC1.48M9.9%SCHEDULE 13G/A ↗
Feb 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Roderick Wong, M.D.1.50M10.0%SCHEDULE 13G/A ↗
Feb 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
RTW Investments, LP1.50M10.0%SCHEDULE 13G/A ↗
Feb 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Eli Casdin1.30M8.7%SCHEDULE 13G/A ↗
Feb 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Casdin Partners GP, LLC1.07M7.2%SCHEDULE 13G/A ↗
Feb 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Casdin Partners Master Fund, L.P.1.07M7.2%SCHEDULE 13G/A ↗
Feb 14, 2025SCHEDULE 13G/A (amended)NGNE
Neurogene Inc.
Casdin Capital, LLC1.30M8.7%SCHEDULE 13G/A ↗

48 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 8:12 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances